Deadline Extended: UICC Online EML Consultation

The WHO has published its full report of the 20th Expert Committee on the Selection and Use of Essential Medicines containing the 2015 WHO Model List of Essential Medicines (EML) and a dedicated cancer chapter. Following the successes of 2015, UICC will be working with WHO on the next cycle of updates to the WHO EML and is calling on Members and interested stakeholders to provide their expert opinions.

Serving as a baseline for national modification, the WHO EML serves as an important starting block in addressing access issues. In 2014, UICC worked with WHO to generate a new methodology for the rational selection of essential cancer medicines with the goal of equipping policy makers with the information to help them determine how to best select medicines that will have a major impact on patients in a national setting. The 2015 list demonstrates a major win for global oncology - featuring 46 cancer medicines and for the first time disease-based listing for both adult and childhood cancers. For more information on the WHO EML, what the 2015 updates mean, and UICCs role, please click here.

UICC is now calling on members and other interested stakeholders to feed their expert opinion into the next cycle of discussion with WHO in order to consolidate the framework adopted in 2015 and contribute to 2017 decision making. For further information and to join the consultation please click here.

CLOSE DATE: Thursday 31 March 2016, 11PM CET